These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

366 related items for PubMed ID: 1116104

  • 1. Adriamycin plus vincristine compared to and combined with cyclophosphamide, methotrexate, and 5-fluorouracil for advanced breast cancer.
    De Lena M, Brambilla C, Morabito A, Bonadonna G.
    Cancer; 1975 Apr; 35(4):1108-15. PubMed ID: 1116104
    [Abstract] [Full Text] [Related]

  • 2. Low dose chemotherapy of metastatic breast cancer with cyclophosphamide, adriamycin, methotrexate, 5-fluorouracil (CAMF) versus sequential cyclophosphamide, methotrexate, 5-fluorouracil (CMF) and adriamycin.
    Creech RH, Catalano RB, Harris DT, Engstrom PF, Grotzinger PJ.
    Cancer; 1979 Jan; 43(1):51-9. PubMed ID: 367574
    [Abstract] [Full Text] [Related]

  • 3. Sequential combination chemotherapy in advanced breast cancer.
    Brambilla C, Valagussa P, Bonadonna G.
    Cancer Chemother Pharmacol; 1978 Jan; 1(1):35-9. PubMed ID: 373906
    [Abstract] [Full Text] [Related]

  • 4. Response and survival in advanced breast cancer after two non-cross-resistant combinations.
    Brambilla C, De Lena M, Rossi A, Valagussa P, Bonadonna G.
    Br Med J; 1976 Apr 03; 1(6013):801-4. PubMed ID: 1260337
    [Abstract] [Full Text] [Related]

  • 5. A comparison of cyclophosphamide, adriamycin, 5-fluorouracil (CAF) and cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, prednisone (CMFVP) in patients with metastatic breast cancer: a Southeastern Cancer Study Group project.
    Smalley RV, Carpenter J, Bartolucci A, Vogel C, Krauss S.
    Cancer; 1977 Aug 03; 40(2):625-32. PubMed ID: 329975
    [Abstract] [Full Text] [Related]

  • 6. CAP (cyclophosphamide, adriamycin, platinum) vs CMFVP (cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, prednisolone) combination chemotherapy in untreated metastatic breast cancer. A preliminary report of a controlled clinical study.
    Kolarić K, Roth A, Vukas D, Cervek J.
    Cancer Chemother Pharmacol; 1984 Aug 03; 13(2):142-4. PubMed ID: 6380789
    [Abstract] [Full Text] [Related]

  • 7. A randomized comparative trial of adriamycin versus methotrexate in combination drug therapy.
    Bull JM, Tormey DC, Li SH, Carbone PP, Falkson G, Blom J, Perlin E, Simon R.
    Cancer; 1978 May 03; 41(5):1649-57. PubMed ID: 348293
    [Abstract] [Full Text] [Related]

  • 8. Vincristine, doxorubicin, and cyclophosphamide versus low-dose intravenous cyclophosphamide, methotrexate, and 5-fluorouracil in advanced breast cancer: a randomized trial of the Piedmont Oncology Association.
    Muss HB, Richards F, Jackson DV, Cooper MR, White DR, Stuart JJ, Ramseur W, Christian RM, Wells HB, Pope E, Spurr CL.
    Cancer; 1982 Dec 01; 50(11):2269-74. PubMed ID: 6754062
    [Abstract] [Full Text] [Related]

  • 9. [Encouraging results with cytostatic therapy in metastasizing breast cancer (author's transl)].
    Michlmayr G, Kratzer H, Denz H, Huber H.
    Wien Klin Wochenschr; 1981 Mar 20; 93(6):205-7. PubMed ID: 7281697
    [Abstract] [Full Text] [Related]

  • 10. First, second and third line chemotherapy programs in metastatic breast carcinoma.
    Rizel S, Sulkes A, Gez E, Brufman G, Biran S.
    Isr J Med Sci; 1981 Mar 20; 17(9-10):946-53. PubMed ID: 6171542
    [Abstract] [Full Text] [Related]

  • 11. A new six-drug antiblastic regimen (R 14) at low doses (micropolychemotherapy) compared to CMF in the treatment of metastatic breast cancer: phase III study.
    Pannuti F, Iafelice G, Martoni A, Fruet F, Angelelli B, Casadei M.
    Chemioterapia; 1984 Aug 20; 3(4):216-9. PubMed ID: 6398121
    [Abstract] [Full Text] [Related]

  • 12. Moderately high-dosage methotrexate medication in metastatic breast cancer.
    Wils JA.
    Neth J Med; 1980 Aug 20; 23(2):59-61. PubMed ID: 7374869
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Adjuvant treatment of node-positive breast cancer with cyclophosphamide, doxorubicin, fluorouracil, and vincristine versus cyclophosphamide, methotrexate, and fluorouracil: final report after a 16-year median follow-up duration.
    Misset JL, di Palma M, Delgado M, Plagne R, Chollet P, Fumoleau P, Le Mevel B, Belpomme D, Guerrin J, Fargeot P, Metz R, Ithzaki M, Hill C, Mathé G.
    J Clin Oncol; 1996 Apr 20; 14(4):1136-45. PubMed ID: 8648368
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Combination chemotherapy and adriamycin in patients with advanced breast cancer. A Southwest Oncology Group study.
    Hoogstraten B, George SL, Samal B, Rivkin SE, Costanzi JJ, Bonnet JD, Thigpen T, Braine H.
    Cancer; 1976 Jul 20; 38(1):13-20. PubMed ID: 947510
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.